Solid Biosciences (SLDB) Invested Capital (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Invested Capital for 8 consecutive years, with $170.4 million as the latest value for Q3 2024.
- Quarterly Invested Capital rose 18.05% to $170.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $170.4 million through Sep 2024, up 18.05% year-over-year, with the annual reading at $126.5 million for FY2023, 40.25% down from the prior year.
- Invested Capital hit $170.4 million in Q3 2024 for Solid Biosciences, down from $193.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $253.0 million in Q1 2021 to a low of $22.2 million in Q3 2020.
- Historically, Invested Capital has averaged $161.5 million across 5 years, with a median of $170.4 million in 2024.
- Biggest five-year swings in Invested Capital: crashed 79.52% in 2020 and later soared 904.74% in 2021.
- Year by year, Invested Capital stood at $132.1 million in 2020, then soared by 57.63% to $208.2 million in 2021, then increased by 1.66% to $211.7 million in 2022, then crashed by 40.25% to $126.5 million in 2023, then soared by 34.74% to $170.4 million in 2024.
- Business Quant data shows Invested Capital for SLDB at $170.4 million in Q3 2024, $193.2 million in Q2 2024, and $210.7 million in Q1 2024.